Trial intelligence / Profile preview

Postpartum blood loss: intravenous oxytocin vs intravenous methylergometrine during third stage of labor

TCTR20120000012Phase 4Completed

Sponsor
Ramathibodi Hospital
Start
Aug 2011
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of oxytocin, methylergometrine in postpartum hemorrhage (PPH), sponsored by Ramathibodi Hospital. Started Aug 2011; status: completed.

02

Drugs

oxytocinmethylergometrine
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on TCTR20120000012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20120000012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call